Management of Covid-19 Patients During Home Isolation

June 19, 2020 updated by: Mahmoud Sedky, Cairo University
This study will be concerned with managing patients of Covid-19 while being home isolated.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt
        • M. Sedky

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with Covid-19
  • American Society of Anesthesiologists (ASA) class I
  • >= 21 years old
  • <= 40 years old

Exclusion Criteria:

  • ASA class II, class III or class IV

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Physical Therapy Group
Procedure: Physical Therapy
Patients receive physical therapy
Experimental: Oxygen Therapy Group
Device: Oxygen Therapy
Patients receive oxygen therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Arterial Blood Gases (ABG): Partial Pressure of Oxygen and Carbon Dioxide
Time Frame: 48 hours
48 hours
Arterial Blood Gases (ABG): Acidity Potential Hydrogen (pH)
Time Frame: 48 hours
48 hours

Secondary Outcome Measures

Outcome Measure
Time Frame
Vital Signs (Temprature)
Time Frame: 24 hours
24 hours
Vital Signs (Respiratory Rate)
Time Frame: 24 hours
24 hours
Vital Signs (Oxygen Saturation)
Time Frame: 24 hours
24 hours
Vital Signs (Heart Rate)
Time Frame: 24 hours
24 hours
Vital Signs (Blood Pressure)
Time Frame: 24 hours
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2020

Primary Completion (Anticipated)

June 21, 2020

Study Completion (Anticipated)

June 23, 2020

Study Registration Dates

First Submitted

April 24, 2020

First Submitted That Met QC Criteria

April 28, 2020

First Posted (Actual)

April 30, 2020

Study Record Updates

Last Update Posted (Actual)

June 23, 2020

Last Update Submitted That Met QC Criteria

June 19, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/012-2020

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid 19

Clinical Trials on Oxygen Therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe